SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Questcor Pharmaceuticals, Inc. (QCOR), OCZ Technology Group, Inc. (OCZ), Ubiquiti Networks, Inc. (UBNT) and Peregrine Pharmaceuticals, Inc. (PPHM)
NEW YORK, Oct. 15, 2012 /PRNewswire/ --
Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )
For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012 to request that the Court appoint you as lead plaintiff.
OCZ Technology Group, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the ND of California on behalf of investors who acquired OCZ Technology Group, Inc. (NASDAQ: OCZ) securities between July 10, 2012 and October 10, 2012.
For more information, click here: http://zlk.9nl.com/OCZ. You have until December 11, 2012 to request that the Court appoint you as lead plaintiff.
Ubiquiti Networks, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the US District Court for the Northern District of California on behalf of investors who purchased Ubiquiti Networks, Inc. (NASDAQ: UBNT) stock between October 14, 2011 and August 9, 2012.
For more information, click here: http://zlk.9nl.com/ubnt. You have until November 6, 2012 to request that the Court appoint you as lead plaintiff.
Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who acquired Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities between August 30, 2012 and September 26, 2012.
For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm. You have until November 27, 2012 to request that the Court appoint you as lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP
RELATED LINKS
http://www.zlk.com
More by this Source
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of SoundBite Communications, Inc. in Connection with the Sale of the Company to Genesys
May 23, 2013, 10:14 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Websense, Inc. in Connection with the Sale of the Company to Vista Equity Partners
May 22, 2013, 10:41 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Theragenics Corporation in Connection with a Going Private Proposal
May 21, 2013, 10:33 ET
Featured Video
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.




